Accuryn Medical

Accuryn Medical is a predictive health company focused on developing advanced medical devices that enhance critical care, particularly in preventing and detecting acute kidney injury (AKI). Originating from Theranova, Accuryn aims to tackle significant healthcare challenges by offering innovative monitoring solutions that improve patient outcomes and support healthcare workers. The flagship product, the Accuryn Monitoring System®, transforms traditional urinary catheters into diagnostic tools. It automates urine output measurement and provides real-time monitoring of intra-abdominal pressure and core body temperature. This system is designed for critical care environments, such as intensive care units and trauma care, reducing the need for manual monitoring and minimizing healthcare workers' exposure to infections. Accuryn Medical primarily serves hospitals and healthcare providers managing critically ill patients. Their technology delivers actionable, real-time data to improve patient monitoring and outcomes, particularly for those at risk of kidney injury. The company adheres to strict regulatory standards to ensure compliance and has a leadership team experienced in healthcare innovation to drive the adoption of their technology.

• Employees 38
• Founded 2011
• Annual Revenue $10000000
• Total Funding $78170568